Shimura Hirohisa
Healthcare Research Center, Crecon Research and Consulting Inc., Tokyo, Japan.
J Mark Access Health Policy. 2018 Jan 18;6(1):1424474. doi: 10.1080/20016689.2018.1424474. eCollection 2018.
: One method for promoting drugs in Japan has been utilizing wholesalers for promotion; however, the effectiveness of the sales promotion has been brought into question. : A total of 74,552 responses were collected from an internet survey of 511 prescribing doctors in hospitals with less than 19 beds, which recalled the visits by wholesalers' sales representatives (MS) in 2014. Each assessed the degree to which MS and/or sales representatives from a pharmaceutical company (MR) influenced a decision to prescribe each drug. The responses were analysed using the chi-square test and Goodman-Kruskal's gamma to evaluate the association between MS calls and doctors' prescription orders. : Results showed a significant effect of the MS calls on doctors' behaviours in terms of new drug prescriptions and subsequent behaviours. The results by therapeutic category showed a similar strong influence of the joint calls on new prescriptions on some therapeutic classes. The MS calls significantly influenced doctors to maintain and increase the prescription volume (p < 0.01). : This paper demonstrates that sales promotion on the part of MSs and MRs adds value to the prescription decisions. Moreover, results suggest that MSs enhance prescription outcomes in competitive therapeutic categories.
在日本,一种药品推广方法是利用批发商进行推广;然而,这种促销方式的效果受到了质疑。对511名在床位少于19张的医院开处方的医生进行了网络调查,共收集到74552份回复,这些回复回忆了2014年批发商销售代表(MS)的来访情况。每位医生评估了MS和/或制药公司销售代表(MR)对其开具每种药物处方决定的影响程度。使用卡方检验和古德曼-克鲁斯卡尔伽玛系数对回复进行分析,以评估MS拜访与医生处方订单之间的关联。结果显示,MS拜访对医生在新药处方及后续行为方面的行为有显著影响。按治疗类别划分的结果显示,联合拜访对某些治疗类别的新处方也有类似的强烈影响。MS拜访显著影响医生维持和增加处方量(p < 0.01)。本文表明,MS和MR的促销活动为处方决策增加了价值。此外,结果表明MS在竞争激烈的治疗类别中提高了处方效果。